eCOA Resources
-
What 4 Things Do All eCOA Studies Need To Succeed?
8/8/2023
Learn what else, in addition to good technology, study teams need for eCOA studies to succeed.
-
Three Benefits Of Centralizing Global Content For eCOA Migration
8/29/2022
Now, more than ever, sponsors aim to empower the global patient voice through patient-centric technologies—including providing wearable technologies and using electronic clinical outcome assessments (eCOAs) to collect patient data.
-
Align eDiary Design With Assessment Schedules
4/2/2025
Ensure alignment with your study protocol by leveraging the Sculptor portal to simulate eDiary completion and top-down scheduling, allowing for real-time preview and modifications.
-
Harness The Power Of eCOA In Your Next Trial
In this webinar, explore the importance of eCOAs, how they have evolved from the standard paper diaries, and what efficiencies you can realize from them.
-
Implementing Caregiver Assessments: Key Considerations
11/16/2023
When caregivers are involved in a clinical trial, remember to utilize these tactics to ensure that the completion of Observer Reported Outcomes is user-friendly and upholds data quality standards.
-
eClinical Platform Accelerates COVID-19 Treatment Trial By 2 Weeks
1/8/2024
Examine a COVID-19 treatment trial that utilized integrated EDC, eConsent, eCOA, RTSM, and TeleVisit solutions, all within a single platform, to address three critical challenges.
-
Navigating The eCOA Vendor Landscape In 2025
8/21/2025
This guide offers a clear-eyed perspective on the current eCOA landscape, providing sponsors with actionable guidance to make confident, informed vendor choices.
-
7 eCOA Design Recommendations: Insights From Sites And CRAs
2/20/2024
Signant joined a group of C-Path members including other eCOA solution providers, sponsors, and regulators for a GBTI project that revealed several opportunities to improve eCOA usability and flexibility.
-
Embracing Accessibility: The Future Of Clinical Trials
10/16/2023
Explore the reasons why accessibility stands as a crucial pillar for the prosperity of biopharmaceutical and clinical research, having evolved into an all-encompassing industry imperative.
-
eCOA And Digital Platforms Reduce Diabetes Study Startup To 8 Weeks
10/18/2023
See how digital solutions came together to enable faster study startup by 50% for this top pharma company conducting a Phase 3 diabetes study within the weight loss market.